Gilead Sciences

Gilead Sciences shows a solid competitive position with solid gross margins of 77.6%. However, returns on capital that fall short of elite levels suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.